PHENYTOIN TOXICITY PRODUCED BY TOLBUTAMIDE

被引:1
作者
BEECH, E
MATHUR, SVS
HARROLD, BP
机构
关键词
D O I
10.1136/bmj.297.6663.1613-c
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1613 / 1614
页数:2
相关论文
共 9 条
[1]   DDAVP AND URINE OSMOLALITY IN REFRACTORY ENURESIS [J].
DIMSON, SB .
ARCHIVES OF DISEASE IN CHILDHOOD, 1986, 61 (11) :1104-1107
[2]  
LASURENO R, 1988, LANCET, V1, P1439
[3]  
MAREK J, 1978, ENDOKRINOLOGIE, V72, P188
[4]  
PANNEKOEK JH, CITED INDIRECTLY
[5]   CHLORIDE IMPERMEABILITY IN CYSTIC-FIBROSIS [J].
QUINTON, PM .
NATURE, 1983, 301 (5899) :421-422
[6]  
REW DA, IN PRESS BR J UROL
[7]   DDAVP (1-DESAMINO-8-D-ARGININE-VASOPRESSIN) TREATMENT OF CENTRAL DIABETES-INSIPIDUS - MECHANISM OF PROLONGED ANTI-DIURESIS [J].
SEIF, SM ;
ZENSER, TV ;
CIAROCHI, FF ;
DAVIS, BB ;
ROBINSON, AG .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1978, 46 (03) :381-388
[8]   FREQUENT ANTIBIOTIC-THERAPY IMPROVES SURVIVAL OF CYSTIC-FIBROSIS PATIENTS WITH CHRONIC PSEUDOMONAS-AERUGINOSA INFECTION [J].
SZAFF, M ;
HOIBY, N ;
FLENSBORG, EW .
ACTA PAEDIATRICA SCANDINAVICA, 1983, 72 (05) :651-657
[9]   INTERACTION OF DIPHENYLHYDANTOIN (DPH) AND TOLBUTAMIDE IN MAN [J].
WESSELING, H ;
MOLSTHURKOW, I .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1975, 8 (01) :75-78